👁️GURU.Markets👁️

🛒 BUY 1 000

🌙

☀️

Lexaria Bioscience Corp. (LEXX) Short-Term Debt to Capital

Lexaria Bioscience (LEXX) leverages the expertise of dedicated DehydraTECH specialists, ensuring zero churn among key developers. The business is striving for patent superiority within the lipid delivery systems niche, where the risk of losing licensing payments stands at 0.01. The price trend on GURU.Markets complements data regarding production environmental optimization and the implementation of ESG standards to reduce industrial waste.

lexariabioscience.com (LEXX) Ratio of Short-Term Indebtedness to Capital: for the period 07/04/2022 - 10/28/2026

Metric breakdowns and analytics for Lexaria (LEXX)

- price and consensus price forecast:

Stock Price Lexaria Bioscience|LEXX - Fair Value Consensus

- market capitalization data:

Market Capitalization Lexaria Bioscience Corp|LEXX - Enterprise Value

- book capitalization data:

Net Assets per Single Share Lexaria Bioscience|LEXX - Accounting Value of Company|Market Value to Book Value Ratio lexariabioscience.com|LEXX - Cumulative Company Assets

- debt and liquidity data:

Total Debt to Capital Lexaria Bioscience|LEXX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Lexaria Bioscience|LEXX - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Lexaria Bioscience Corp

General company analysis:Lexaria Bioscience Corp. (LEXX)

Logistics optimization for drug delivery at Lexaria Bioscience (LEXX) directly impacts the ratio of short-term borrowing to equity, reflecting the dependence of operating profitability on external financing. This metric compares liabilities with maturities exceeding one year against equity, allowing investors to assess the risk of cash flow gaps during the scaling of pharmaceutical raw material procurement and the issuer's overall debt sustainability.

Competitors of Lexaria Bioscience

Haleon Group (HLN) - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Kenvue Health (KVUE)|Short-Term Debt to Capital VRNA (Verona Pharma plc)|jyongbio.com - Short-Term Debt to Capital|Short-Term Debt to Equity Ligand (LGND)|AMRX: Ratio of Short-Term Indebtedness to Capital|PRGO (Perrigo Company) - Short-Term Debt to Equity|Alvotech Biopharmaceuticals (ALVO) - Short-Term Debt to Equity Ratio|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com (GLPG)|ANI Pharmaceuticals, Inc. (ANIP) - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital MNKD (MannKind Corp)|AMPH: Short-Term Debt to Equity|PCRX - Current Liabilities to Capital|Short-Term Debt to Equity Ratio ARS Pharmaceuticals SPRY|TBPH - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital Aquestive Therapeutics, Inc. AQST|scPharmaceuticals (SCPH) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital TECX (Tectonic Therapeutic Inc.)|Current Liabilities to Capital TNXP|China SXT Pharmaceuticals (SXTC) - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital EPRX (eupraxiapharma.com)|Short-Term Debt to Equity BioHarvest Sciences Inc. BHST|Short-Term Debt to Equity Invizyne Technologies EXOZ|ORMP (Oramed Pharma) - Short-Term Debt to Capital|Entera Bio Ltd. (ENTX) - Current Liabilities to Capital|Short-Term Debt to Equity Ratio MindWalk Holdings|abvcpharma.com (ABVC) - Short-Term Debt to Capital Ratio|CPIX (Cumberland Pharmaceuticals Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital QNTM|FibroGen Corp (FGEN) - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Telomir Pharmaceuticals Corp (TELO)|Short-Term Debt to Capital RANI|Short-Term Debt to Capital Coefficient Synergy CHC Corp. SNYR|Rallybio Corp. - Short-Term Debt to Capital|Pulmatrix Inc (PULM) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio ftzy.com.cn PTHL|Aptorum Group (APM) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital Lyra Therapeutics, Inc.|Short-Term Debt to Equity impactbiomedinc.com|TNFA (TNF Pharmaceuticals) - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient YCBD (cbdmd.com)|PRFX: Short-Term Debt to Equity|Altamira Therapeutics Ltd - Current Liabilities to Capital|Short-Term Debt to Equity LIPO (Lipella Pharmaceuticals)|OPTN - Short-Term Debt to Capital Coefficient|PIRS (Pieris Pharmaceuticals, Inc.) - Short-Term Debt to Capital|Procaps Group (PROC) - Short-Term Debt to Equity Ratio|PTPI: Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Qilian International Corp|Acelyrin, Inc. - Short-Term Debt to Capital|Current Liabilities to Capital TFFP (tffpharma.com)